Download Free Sample
captcha refresh

Single Cell Protein Products Market Size, Share, Growth, and Industry Analysis, By Type (Yeast, Algae, Bacteria, Others), By Application (Animal Feed, Human Food), Regional Insights and Forecast From 2026 To 2035

Single Cell Protein Products Market Overview

The global single cell protein products market is projected to grow from USD 6777.32 Million in 2026 to USD 10972.27 Million by 2035, registering a CAGR of 5.5% during the forecast period. Increasing demand for sustainable protein sources, rising interest in alternative nutrition, and growing applications across food, feed, and biotechnology are supporting market expansion. Advances in microbial fermentation, improved production efficiency, and growing awareness of resource-efficient protein solutions are further creating opportunities for manufacturers and strengthening the market’s long-term growth prospects.

The global Single Cell Protein Products Market is expanding as food and feed manufacturers seek protein ingredients that can be produced through controlled microbial processes rather than conventional livestock agriculture. The global single-cell protein market was valued at USD 12.33 billion in 2025, reflecting the increasing commercial importance of microbial biomass as an alternative protein source. Single cell protein products are produced from microorganisms including yeast, algae, bacteria, and fungi, with applications spanning animal nutrition, aquaculture, pet nutrition, food ingredients, dietary products, and specialized nutrition. Fermentation-based production can utilize agricultural by-products, industrial substrates, gases, and other feedstocks, creating opportunities for resource-efficient protein manufacturing and circular bioeconomy models.

The United States represents an important Single Cell Protein Products Market because the country has a large animal-feed industry, sophisticated food-processing infrastructure, biotechnology capabilities, and increasing interest in alternative protein ingredients. The U.S. market is supported by demand for high-quality feed proteins that can complement conventional soybean meal, fishmeal, and other protein sources. Animal nutrition companies are evaluating microbial proteins for poultry, aquaculture, livestock, and pet applications because controlled fermentation can provide consistent nutritional characteristics. Human-food applications are also receiving attention through nutritional yeast, algae-derived ingredients, protein powders, and fermentation-derived functional ingredients. Regulatory evaluation, consumer acceptance, ingredient functionality, and production economics remain important factors shaping commercial adoption within the U.S. market.

Key Report Takeaways

  • By Type: Algae is anticipated to be the fastest-growing type, with an estimated CAGR of 6.4%, driven by increasing interest in nutrient-rich and sustainable protein alternatives.
  • By Application: The segment is expected to register a CAGR of 5.7%, supported by expanding feed production and growing demand for efficient nutritional ingredients.
  • By Solution Category: Algae-based protein solutions are expected to be the fastest-growing category, with an estimated CAGR of 6.4%, supported by growing interest in sustainable protein production and alternative nutritional ingredients.
  • By End User: Food manufacturers are also increasing adoption as consumer interest in alternative protein sources, nutritional products, and sustainable food ingredients continues to strengthen.
  • By Geography: Asia Pacific is projected to be the fastest-growing region, with an estimated CAGR of 6.8%, driven by expanding livestock production, rising food demand, increasing protein consumption, and growing interest in sustainable nutritional solutions.
Global Single Cell Protein Products Market Size,

The Single Cell Protein Products Market is increasingly moving toward fermentation systems that convert low-value substrates into high-value protein biomass. Producers are examining methanotrophic bacteria, yeast, algae, and other microorganisms capable of growing on alternative carbon sources, including industrial by-products and gases. A major technology direction involves integrating protein production with waste-management systems so that one process can generate both environmental benefits and nutritional products. Research published in 2025 demonstrated production of single cell protein and pyrroloquinoline quinone from molasses and biogas slurry, achieving a single-cell protein titer of 35.6 grams per liter in a fermenter. Such developments illustrate the potential for multifunctional fermentation platforms that produce protein while recovering value from underutilized resources. Yeast protein is also gaining momentum because yeast has established industrial fermentation infrastructure, recognized nutritional characteristics, and broad application experience. Angel Yeast showcased its AngeoPro yeast protein at Vitafoods India 2025, positioning the ingredient for human nutrition applications and emphasizing digestibility, amino-acid composition, and sustainability. The company also completed the topping-out milestone for a yeast-protein production project designed for annual output of 11,000 tons. These developments indicate a movement from laboratory-scale alternative-protein research toward larger commercial manufacturing systems. At the same time, algae and bacterial proteins are receiving attention for feed, aquaculture, food, and functional nutrition applications, expanding the technological diversity of the Single Cell Protein Products Market.

Single Cell Protein Products Market Dynamics

DRIVER

"Rising demand for sustainable alternative protein sources"

The increasing requirement for sustainable protein is a major driver of the Single Cell Protein Products Market because microbial fermentation can produce protein without depending exclusively on conventional livestock production. Population growth, pressure on agricultural land, feed-resource constraints, and concerns regarding greenhouse-gas emissions are encouraging manufacturers to evaluate alternative protein systems. Single cell protein can be produced using controlled fermentation, allowing manufacturers to manage temperature, pH, oxygen, nutrient availability, and microbial growth inside industrial reactors. This controlled environment can provide consistent production throughout the year and reduce dependence on seasonal agricultural cycles. Animal-feed manufacturers are particularly interested because microbial proteins can complement conventional feed ingredients and potentially reduce dependence on soybean meal and fishmeal. The animal-feed segment is therefore an important commercial pathway for scaling Single Cell Protein Products before broader human-food adoption.

RESTRAINT

"High production costs and processing requirements"

Production economics remain a major restraint because commercial single cell protein manufacturing requires fermentation equipment, sterile or controlled processing environments, downstream separation, drying, quality testing, and reliable feedstock supplies. Energy consumption can also become significant when microorganisms require aeration, temperature control, agitation, or specialized downstream processing. The economics vary substantially according to the microorganism and substrate used. Protein produced from inexpensive industrial by-products may have a stronger cost position than protein produced using refined nutrients. Product developers must also manage nucleic-acid levels, unwanted metabolites, microbial contamination, moisture, flavor, color, and storage stability. Human-food applications generally require more extensive purification and sensory optimization than many feed applications, potentially increasing production costs. These factors can slow commercialization when microbial protein must compete directly with established low-cost protein commodities.

OPPORTUNITY

"Integration of waste streams with microbial protein production"

Waste-stream utilization represents a significant opportunity because fermentation systems can convert materials with limited economic value into protein-rich biomass. Agricultural residues, molasses, food-processing by-products, industrial gases, and other substrates can potentially serve as microbial feedstocks after suitable processing and safety evaluation. Research published in 2025 demonstrated that molasses and biogas slurry could support microbial production of single cell protein alongside another valuable compound, indicating the potential for integrated biorefinery models. The process achieved 35.6 grams per liter of single cell protein under optimized fermentation conditions. Such systems can create additional revenue streams from waste while reducing resource losses. Commercial opportunities are particularly attractive where inexpensive feedstocks are locally available near fermentation facilities, reducing transportation costs and improving overall resource efficiency.

CHALLENGE

"Regulatory approval, sensory acceptance and nutritional consistency"

Regulatory compliance remains a major challenge for the Single Cell Protein Products Market because products intended for human consumption must satisfy requirements concerning microbial identity, production substrates, contaminants, allergens, nutritional composition, processing conditions, and intended use. Animal-feed products also require safety assessment and consistent nutritional specifications. Human consumers may additionally evaluate microbial proteins according to taste, texture, appearance, digestibility, processing methods, and perceptions surrounding fermentation. Some microbial biomass can contain substantial nucleic-acid levels that require controlled processing before human consumption. Manufacturers therefore need robust analytical systems covering amino acids, proteins, fats, minerals, nucleic acids, contaminants, and microbiological safety. Maintaining consistent composition across fermentation batches is equally important because food and feed manufacturers need predictable ingredient performance in finished products.

Single Cell Protein Products Market Segmentation

The Single Cell Protein Products Market is segmented according to microbial source and end-use application. Yeast products benefit from mature fermentation infrastructure and established use in food and feed industries, while algae provide proteins, pigments, lipids, minerals, and other nutritional compounds. Bacterial proteins offer opportunities for rapid biomass production and the utilization of unconventional feedstocks, including methane and industrial substrates. Other sources include fungi and specialized microorganisms developed for alternative-protein applications. Animal feed remains a significant commercial pathway because livestock, poultry, aquaculture, and pet nutrition industries require reliable protein ingredients. Human food provides another major opportunity through nutritional proteins, functional ingredients, supplements, and alternative-food formulations.
Global Single Cell Protein Products Market Size, 2035

By Type

Based on Type, the Global market can be categorized into, Yeast, Algae, Bacteria, Others

  • [Yeast]: Yeast represents one of the most established sources within the Single Cell Protein Products Market because industrial fermentation infrastructure for yeast production already exists across baking, brewing, food ingredients, biotechnology, and animal nutrition. Yeast biomass can provide protein, amino acids, vitamins, minerals, and functional compounds, allowing manufacturers to develop products for both feed and human nutrition. Yeast protein is particularly attractive because production systems can be optimized through strain selection, fermentation control, nutrient management, and downstream processing. Angel Yeast's AngeoPro product demonstrates the movement of yeast-derived protein into human nutrition, while established companies such as Lesaffre and Lallemand provide extensive fermentation expertise. Yeast also offers opportunities for protein extraction, nutritional yeast products, feed additives, and specialized functional ingredients.
  • [Algae]: Algae represents a valuable segment because microalgae can produce protein alongside pigments, lipids, minerals, antioxidants, and other bioactive compounds. Spirulina and chlorella are among the best-known algae sources used in nutritional products, supplements, animal nutrition, and specialty ingredients. Algae cultivation can take place in controlled photobioreactors or open systems depending on the microorganism and application. The protein content and functional characteristics of algae vary according to species, cultivation conditions, harvesting methods, and processing technology. Algae-based products are particularly attractive for premium nutrition markets because consumers often associate them with natural ingredients and sustainable production. However, manufacturers must manage taste, color, processing cost, contamination risk, and scalability to compete effectively with established protein ingredients.
  • [Bacteria]: Bacterial protein is gaining importance within the Single Cell Protein Products Market because certain microorganisms can grow rapidly and utilize carbon sources that are unsuitable for conventional agriculture. Methanotrophic bacteria are particularly promising because they can convert methane into microbial biomass, potentially linking protein production with greenhouse-gas management. Bacterial systems can also use hydrogen, carbon dioxide, methanol, and industrial by-products depending on the organism and fermentation design. The resulting biomass can contain substantial protein and may be suitable for animal nutrition following appropriate processing and safety evaluation. Commercial development depends heavily on reactor efficiency, gas transfer, feedstock purity, downstream recovery, and regulatory acceptance. Improvements in bioreactor engineering could help bacterial protein transition from specialized applications toward larger feed and food markets.
  • [Others]: The Others segment includes fungal biomass and other microorganisms that do not fall directly within yeast, algae, or bacterial categories. Filamentous fungi and mycelial systems can provide protein-rich biomass with useful texture, water-binding properties, and functional characteristics. These attributes create opportunities for human-food applications such as meat alternatives and structured protein products. Fungal fermentation can also utilize carbohydrate-rich substrates and agricultural residues, creating potential circular-economy benefits. Researchers are investigating high-throughput fermentation methods for producing mycoprotein from lignocellulosic hydrolysates, demonstrating the potential to transform plant residues into protein ingredients. Product developers must optimize strain performance, substrate utilization, texture, flavor, and downstream processing to achieve commercially attractive results.

By Application

Based on Application, the Global market can be categorized into, Animal Feed, Human Food

  • [Animal Feed]: Animal Feed is a major application for the Single Cell Protein Products Market because feed manufacturers require scalable protein sources for poultry, livestock, aquaculture, and companion animals. Single cell protein can provide amino acids and other nutritional components while reducing dependence on conventional protein ingredients. Aquaculture is particularly relevant because fishmeal availability and cost can influence feed economics, creating demand for alternative protein ingredients. Yeast and bacterial proteins can also provide functional benefits beyond protein content, including potential effects on gut health and feed utilization. Research into yeast-based animal nutrition has highlighted interest in organisms such as Yarrowia lipolytica because microbial biomass can provide protein and lipid components. Commercial adoption depends on demonstrated animal performance, feed conversion, palatability, safety, consistency, and competitive pricing.
  • [Human Food]: Human Food represents a growing opportunity because consumers and food manufacturers are searching for protein ingredients that can supplement conventional plant and animal sources. Single cell protein can be incorporated into nutritional powders, sports nutrition, bakery products, snacks, meat alternatives, beverages, and specialized dietary formulations depending on the source and regulatory status. Yeast protein is particularly attractive because established fermentation systems can support consistent production, while algae provide additional nutritional compounds. Product developers must focus strongly on taste, texture, color, digestibility, allergen management, and consumer familiarity. Angel Yeast's AngeoPro launch activity in India demonstrates the increasing effort to position yeast protein as a human nutrition ingredient. The segment will depend on regulatory approvals, sensory acceptance, price competitiveness, and effective communication of nutritional and sustainability attributes.

Single Cell Protein Products Market Regional Outlook

Global Single Cell Protein Products Market Share, By Type 2035
  • North America

North America represents a significant Single Cell Protein Products Market because the region combines advanced biotechnology capabilities with extensive animal-feed, aquaculture, food-processing, and alternative-protein industries. The United States has strong research capabilities in fermentation, microbial engineering, synthetic biology, food science, and animal nutrition. These capabilities provide a foundation for developing microbial proteins with improved amino-acid profiles, digestibility, taste, functionality, and production efficiency. Feed manufacturers are particularly interested in alternatives that can complement soybean meal and fishmeal. Human-food companies are also evaluating fermentation-derived ingredients for protein enrichment and functional nutrition. Commercial adoption benefits from established food-processing infrastructure and sophisticated ingredient-distribution networks, although regulatory approval and production cost remain important barriers. The region is also witnessing increased interest in methane-utilizing microorganisms because microbial protein production can potentially combine environmental and nutritional objectives. Research and commercial projects are exploring microbial systems that consume methane and convert it into protein-rich biomass. One U.S. project involving methane-eating microbes reported methane reductions exceeding 85% during testing while investigating protein-rich biomass as a potential animal-feed ingredient. Such approaches could create a new category of circular protein production in which environmental mitigation generates a valuable co-product. The commercial model remains dependent on feed safety, consistent biomass quality, reactor economics, and regulatory acceptance, but the technology demonstrates how North American companies can connect climate-oriented biotechnology with the Single Cell Protein Products Market.
  • Europe

Europe is an important Single Cell Protein Products Market because the region has strong biotechnology capabilities, advanced fermentation expertise, sustainability policies, and established interest in alternative protein systems. European companies and research institutions are investigating microbial proteins for food, feed, aquaculture, and industrial applications. The region's emphasis on resource efficiency encourages technologies capable of converting waste streams, gases, and industrial by-products into nutritional ingredients. Regulatory scrutiny is comparatively significant, making safety validation and traceability central to commercialization. European producers are therefore investing in strain development, fermentation control, downstream processing, ingredient functionality, and environmental assessment to demonstrate the value of microbial protein systems. The European market also benefits from strong interest in circular bioeconomy models. Single cell protein can potentially connect agriculture, food processing, waste management, biotechnology, and feed manufacturing through integrated production systems. Companies can use fermentation to transform low-value substrates into standardized ingredients while reducing dependence on imported protein commodities. Research into fungal and yeast proteins is particularly relevant to European alternative-food development because these organisms can provide useful texture and nutritional functionality. Investment in precision fermentation infrastructure is increasing the technological capabilities available to protein developers. Future market development will depend on regulatory pathways, consumer acceptance, cost reduction, feedstock availability, environmental performance, and the ability to scale fermentation facilities efficiently.
  • Asia-Pacific

Asia-Pacific is a major opportunity region for the Single Cell Protein Products Market because it combines large populations, substantial animal-feed demand, expanding aquaculture, established fermentation industries, and increasing interest in sustainable food production. China is an important manufacturing center for microbial ingredients, while Japan and South Korea have advanced food biotechnology capabilities. India provides opportunities through its growing nutrition market, large livestock sector, expanding food-processing industry, and increasing consumer interest in alternative proteins. Fermentation technology is already deeply embedded in regional food production, providing technical familiarity that can support the development of yeast and microbial protein products. Large domestic markets can also help companies achieve production scale before expanding internationally. China's biotechnology sector is increasingly aligned with national priorities around food security, agricultural modernization, and synthetic biology. Fushine stated in 2025 that its microbial protein business was being developed alongside broader policy support for biotechnology and diversified food systems. India is also becoming an important commercial market for yeast protein, with Angel Yeast presenting AngeoPro at a major nutrition event in Mumbai during 2025. These developments demonstrate increasing regional attention toward microbial proteins for human nutrition. Asia-Pacific companies can benefit from local feedstocks, lower manufacturing costs, extensive food-processing networks, and large consumer markets. Competition will depend on quality, regulatory compliance, production scale, formulation capabilities, and the ability to adapt microbial protein products to local dietary preferences.
  • Middle East & Africa

Middle East & Africa represent an emerging Single Cell Protein Products Market because many countries face constraints involving water availability, arable land, feed imports, and food-security resilience. Fermentation-based protein production can operate in controlled environments and potentially use locally available industrial feedstocks, making microbial protein attractive for regions seeking alternatives to resource-intensive agricultural production. Saudi Arabia is particularly important because the country has substantial industrial infrastructure and natural-gas resources that can support methane-based microbial protein production. Unibio and Saudi Industrial Investment Group have been developing plans for a large single-cell protein plant in Saudi Arabia based on vertical-loop bioreactor technology and natural gas as feedstock. The project illustrates the region's potential to connect energy resources with protein manufacturing. Africa also presents opportunities through livestock, poultry, aquaculture, food security programs, and industrial biotechnology development. Local microbial protein production could reduce dependence on imported feed ingredients while creating new value from agricultural and industrial residues. However, commercial adoption requires reliable energy, fermentation infrastructure, feedstock supply, water management, skilled personnel, quality-control systems, and regulatory frameworks. Middle Eastern producers can potentially focus on large centralized facilities because industrial infrastructure and energy resources support high-capacity fermentation. African markets may initially favor smaller decentralized systems linked to local agricultural or food-processing operations. Strategic partnerships between biotechnology companies, feed manufacturers, energy companies, agricultural businesses, and governments can help develop the infrastructure required for commercial-scale Single Cell Protein Products.

Key Industry Players

The Single Cell Protein Products Market includes established fermentation companies, specialty protein developers, biotechnology businesses, nutritional-ingredient manufacturers, and emerging microbial-protein producers. Lesaffre, AB Mauri, Angel Yeast, Lallemand, Pakmaya, Tangshan Top Bio Technology, Unibio International, Valensa International, Cell Sustainable Nutrition, and BIOMIN are among the companies associated with the market landscape. Competitive positioning depends on fermentation expertise, microorganism selection, production capacity, feedstock access, downstream processing, product quality, application development, and distribution. Established yeast companies possess an advantage because they already operate industrial fermentation infrastructure and maintain relationships with food and feed manufacturers. Emerging companies are differentiating through methane fermentation, novel microbial strains, waste-stream utilization, precision fermentation, and specialized human nutrition products. Industry strategies are increasingly focused on biotechnology innovation, sustainable feedstocks, production efficiency, strategic partnerships, and product diversification. Lesaffre entered an exclusive global partnership with MicroBioGen in 2025 to combine yeast biotechnology with fermentation and bioengineering capabilities across baking, food, and biochemical markets. Angel Yeast continued expanding yeast-protein production capabilities while promoting AngeoPro for human nutrition applications. Unibio has focused on improving its single-cell protein production process to reduce dependence on natural-gas infrastructure and increase process simplicity and efficiency. These initiatives demonstrate that companies are competing not only through protein volume but also through strain engineering, fermentation productivity, feedstock flexibility, sustainability, and application-specific product performance. Emerging players are creating opportunities in microbial protein for pet food, aquaculture, livestock, functional nutrition, and alternative foods. Methane-based systems represent a particularly distinctive niche because the same biological process can potentially address methane emissions and generate protein biomass. Partnerships with energy companies, food manufacturers, feed producers, biotechnology firms, and research institutions can accelerate commercialization by combining infrastructure with technical expertise. Regional expansion is also becoming important, particularly in Asia-Pacific and the Middle East where large-scale fermentation facilities can benefit from available feedstocks and expanding protein demand. Future competition is likely to favor companies capable of reaching commercial scale while maintaining consistent nutritional quality, regulatory compliance, environmental performance, and cost competitiveness.

List of Top Single Cell Protein Products Companies

  • Lesaffre
  •  AB Mauri
  •  Angel Yeast
  •  Lallemand
  •  Pakmaya
  •  Tangshan Top Bio Technology
  •  Unibio International
  •  Valensa International
  •  Cell Sustainable Nutrition
  •  BIOMIN (ERBER Group)

Top Two Companies with Highest Market Share

  • Lesaffre holds an estimated 12% share of the selected global yeast-derived single cell protein and nutritional yeast segment, supported by extensive fermentation expertise, global manufacturing infrastructure, research capabilities, and established relationships across food, feed, and biotechnology applications.
  • Angel Yeast holds an estimated 9% share of the selected yeast-based single cell protein segment, supported by large-scale yeast manufacturing, dedicated yeast-protein development, international distribution, and its AngeoPro human nutrition product portfolio. The company's industrial yeast protein project is designed for annual output of 11,000 tons, highlighting its manufacturing scale.

Investment Analysis and Opportunities

Investment opportunities in the Single Cell Protein Products Market are increasingly centered on fermentation capacity, microbial strain development, downstream processing, sustainable feedstocks, and application-specific protein formulations. Companies that can achieve higher biomass productivity while reducing energy, water, and nutrient requirements can improve the economics of microbial protein. Large-scale facilities represent an important investment category because commercial adoption depends on reliable production volumes and consistent quality. Angel Yeast's yeast-protein project, designed for annual output of 11,000 tons, illustrates the movement toward dedicated industrial capacity. Investors can also target technologies that transform methane, molasses, agricultural residues, and other low-value materials into protein biomass, creating potential circular-economy advantages. Animal feed provides an attractive investment pathway because manufacturers can introduce microbial protein as a functional ingredient before pursuing broader human-food markets. Aquaculture, poultry, livestock, and pet nutrition each provide opportunities for specialized formulations. Human food offers additional potential through nutritional yeast, protein powders, functional beverages, bakery ingredients, and alternative-food formulations. Investment opportunities also exist in fermentation equipment, process-control software, microbial strain libraries, analytical testing, drying technology, and ingredient formulation. Strategic partnerships can reduce commercialization risks by connecting biotechnology developers with established feed manufacturers and food companies. Companies that demonstrate measurable improvements in feed efficiency, nutritional performance, sensory quality, or environmental impact can strengthen their ability to secure commercial contracts and expansion capital.

New Product Development

New product development in the Single Cell Protein Products Market is increasingly focused on improving protein concentration, amino-acid balance, digestibility, taste, texture, and functional performance. Yeast protein developers are introducing products designed specifically for human nutrition rather than treating microbial biomass solely as a feed ingredient. Angel Yeast's AngeoPro has been positioned around digestibility, amino-acid composition, and sustainability, demonstrating the industry's movement toward premium protein ingredients. Other developers are investigating bacterial and fungal biomass for meat alternatives, aquaculture feeds, pet nutrition, and functional ingredients. Advanced fermentation control, microbial strain selection, nutrient optimization, and downstream separation are allowing producers to tailor biomass characteristics for specific applications rather than selling generic microbial protein. Technology development is also moving toward multifunctional fermentation systems capable of producing protein alongside additional valuable compounds. Research using Hyphomicrobium denitrificans demonstrated simultaneous production of single cell protein and pyrroloquinoline quinone from molasses and biogas slurry, with the optimized system achieving 35.6 grams per liter of single cell protein and 235.1 milligrams per liter of PQQ. Such approaches can improve facility economics by generating multiple products from a shared fermentation platform. Process developers are also investigating unconventional substrates, including lignocellulosic hydrolysates and methane, to reduce dependence on refined agricultural inputs. These innovations can broaden the feedstock base and improve the sustainability profile of microbial protein production.

Five Recent Developments

  • January 2025: Angel Yeast expanded its industrial yeast protein initiative by completing the topping-out milestone for the main plant at its Baiyang Yichang project. The facility is designed for annual production capacity of 11,000 tons of yeast protein. The development strengthens the company's alternative-protein manufacturing infrastructure and supports broader commercialization of fermentation-derived protein for food and nutrition applications.
  • February 2025: Angel Yeast showcased AngeoPro yeast protein at Vitafoods India, presenting the ingredient as a human nutrition protein with emphasis on digestibility, amino-acid composition, and sustainability. The initiative targeted nutrition brands, health professionals, distributors, and consumers interested in alternative proteins. The development strengthens yeast protein commercialization in India and expands awareness of microbial-derived protein within the nutrition sector.
  • February 2025: Unibio received publication of a patent application covering an improved single cell protein production process designed to reduce dependence on natural-gas infrastructure and improve fermentation efficiency. The process aims to increase production flexibility, simplify plant requirements, reduce environmental impact, and improve productivity. The development supports Unibio's broader strategy of making microbial protein technology more adaptable to different industrial production environments.
  • June 2025: Lesaffre and MicroBioGen established an exclusive global partnership combining advanced yeast biotechnology with Lesaffre's bioengineering, fermentation expertise, research capabilities, and production network. The collaboration initially targets baking, food, and biochemical applications while allowing potential expansion into additional areas. The partnership strengthens yeast-platform innovation and creates opportunities for developing improved microbial strains and fermentation-derived products.
  • October 2025: Researchers demonstrated an integrated fermentation process using Hyphomicrobium denitrificans to produce single cell protein and pyrroloquinoline quinone from molasses and biogas slurry. The optimized process achieved a single cell protein titer of 35.6 grams per liter while generating 235.1 milligrams per liter of PQQ. The development highlights opportunities to combine waste valorization, microbial protein production, and high-value coproduct manufacturing.

Report Coverage of Single Cell Protein Products Market

The Single Cell Protein Products Market report covers microbial sources, product categories, applications, regional markets, competitive structures, technology developments, investment opportunities, and strategic initiatives shaping the global industry. Source analysis includes yeast, algae, bacteria, and other microbial systems, while application analysis evaluates animal feed and human food. The report examines fermentation technologies, microbial strain development, substrate utilization, biomass recovery, drying, purification, nutritional composition, quality control, and formulation. It also considers the growing role of alternative feedstocks such as agricultural residues, molasses, industrial by-products, methane, and other carbon sources. Market analysis evaluates how microbial protein can contribute to resource efficiency and circular bioeconomy models. Regional coverage includes North America, Europe, Asia-Pacific, and Middle East & Africa, with attention to biotechnology infrastructure, feed industries, food-processing capabilities, regulatory conditions, investment activity, consumer acceptance, and local protein requirements. Competitive analysis evaluates Lesaffre, AB Mauri, Angel Yeast, Lallemand, Pakmaya, Tangshan Top Bio Technology, Unibio International, Valensa International, Cell Sustainable Nutrition, and BIOMIN. The report also examines emerging technologies including methane-based fermentation, waste-stream protein production, multifunctional biorefinery systems, advanced strain engineering, and precision fermentation. Strategic analysis covers partnerships, production expansions, product launches, intellectual-property development, application diversification, sustainability initiatives, and commercialization pathways. The coverage supports strategic planning for protein manufacturers, feed companies, food producers, biotechnology firms, investors, ingredient suppliers, and organizations evaluating opportunities in the Single Cell Protein Products Market.

Single Cell Protein Products Market Report Coverage

REPORT COVERAGE DETAILS
Market Size Value In USD 6777.32 Million in 2026
Market Size Value By USD 10972.27 Million by 2035
Growth Rate CAGR of 5.5% from 2026-2035
Forecast Period 2026 - 2035
Base Year 2025
Historical Data Available Yes
Regional Scope Global
Segments Covered
By Type Yeast | Algae | Bacteria | Others
By Application Animal Feed | Human Food

Frequently Asked Questions

The global single cell protein products market is expected to reach USD 125260.61 million by 2035.

The single cell protein products market is expected to exhibit a CAGR of 5.5% by 2035.

The dominating companies in the single cell protein products market are .

The single cell protein products market is expected to be valued at 6777.32 million USD in 2026.

OUR
CLIENTS

Google Bosch Pfizer Sony Deloitte Accenture Dupont BASF Ansell Nvidia Airbus Dell Fresenius Siemens abbott yamaha samsung Duracell novonordisk huawei UPS Deloitte Fresenius yamaha samsung uniliver Amgen Kohler Samyang kaman Gallagher hoerbiger Itochu ITIC kINSEY EY Mitsubishi Staller